Postmenopausal women taking anastrozole as a chemopreventive treatment do not have impaired cognitive performance

Sep 05, 2008

New results of a sub-study carried out as part of a worldwide breast cancer prevention study (IBIS-II) show that after two years of taking the aromatase inhibitor, anastrozole, postmenopausal women at high risk of breast cancer do not have impaired cognitive performance.

Early data on women using hormone replacement therapy (HRT) suggested oestrogen was important for maintaining levels of cognition and that reducing oestrogen levels might have a detrimental effect on this function. However, results of this sub-study do not support this belief.

The aim of the cognitive sub-study was to compare the effect of anastrozole on memory and attention in women enrolled in the IBIS-II breast cancer prevention study. Lead researcher Dr Valerie Jenkins from Cancer Research UK Psychosocial Oncology Group at the University of Sussex, assessed 227 women for psychological morbidity, endocrine symptoms and self-reported cognitive complaints. The women were interviewed by psychologists and given tasks including auditory verbal tasks, logical memory tasks and spatial span tests. Assessments were made at baseline, 6 months and 24 months after the start of treatment.

The results published in The Lancet Oncology showed no significant differences between the anastrozole group and the placebo group in terms of changes of attention or memory or in proportions of women experiencing psychological distress. The only difference observed between the groups was that significantly more women in the anastrozole group reported hot flushes.

Dr Valerie Jenkins said: "These findings should be reassuring in the short term for postmenopausal women being treated with anastrozole, their clinicians and carers."

IBIS-II lead researcher Professor Jack Cuzick from Barts and Ther London’s School of Medicine and Dentistry’s Centre for Epidemiology, Mathematics and Statistics said: "Because the IBIS-II trial is studying healthy women it is important to investigate any possible side effects of the treatment in great detail. These results provide reassurance that taking anastrozole will not impair cognitive performance."

Source: Queen Mary, University of London

Explore further: Presence of peers ups health workers' hand hygiene

add to favorites email to friend print save as pdf

Related Stories

Team improves solar-cell efficiency

5 hours ago

New light has been shed on solar power generation using devices made with polymers, thanks to a collaboration between scientists in the University of Chicago's chemistry department, the Institute for Molecular ...

Calif. teachers fund to boost clean energy bets

5 hours ago

The California State Teachers' Retirement System says it plans to increase its investments in clean energy and technology to $3.7 billion, from $1.4 billion, over the next five years.

Alibaba surges in Wall Street debut

5 hours ago

A buying frenzy sent Alibaba shares sharply higher Friday as the Chinese online giant made its historic Wall Street trading debut.

Dwindling wind may tip predator-prey balance

5 hours ago

Bent and tossed by the wind, a field of soybean plants presents a challenge for an Asian lady beetle on the hunt for aphids. But what if the air—and the soybeans—were still?

Recommended for you

Sierra Leone faces criticism over Ebola shutdown

12 hours ago

Sierra Leone began the second day of a 72-hour nationwide shutdown aimed at containing the spread of the deadly Ebola virus on Saturday amid criticism that the action was a poorly planned publicity stunt.

Presence of peers ups health workers' hand hygiene

Sep 19, 2014

(HealthDay)—The presence of other health care workers improves hand hygiene adherence, according to a study published in the October issue of Infection Control and Hospital Epidemiology.

Sierra Leone streets deserted as shutdown begins

Sep 19, 2014

Sierra Leone's normally chaotic capital resembled a ghost town on Friday as residents were confined to their homes for the start of a three-day lockdown aimed at halting the deadly Ebola epidemic.

Sierra Leone launches controversial Ebola shutdown

Sep 19, 2014

Sierra Leone on Friday launched a controversial three-day shutdown to contain the deadly spread of the Ebola virus, as the UN Security Council declared the deadly outbreak a threat to world peace.

User comments : 0